Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPACT: Peanut OIT in Young Children
NCT01867671Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Aug 2013
- Primary completion
- Jul 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of peanut oral immunotherapy (UNC Chapel Hill) in peanut allergy, sponsored by National Institute of Allergy and Infectious Diseases. Started Aug 2013; status: completed.
02
Drugs
peanut oral immunotherapy (UNC Chapel Hill)
03
Conditions
peanut allergy
Beyond the preview
Go deeper on NCT01867671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01867671.